Last month’s performance of -17.04% for Biomarin Pharmaceutical Inc (BMRN) is certainly impressive
On Thursday, Biomarin Pharmaceutical Inc (NASDAQ: BMRN) was 0.60% up from the session before settling in for the closing price of $58.82. A 52-week range